SaaS and Biotech: Accelerating Drug Discovery
Drug discovery is increasingly a software-and-data problem: integrating messy multi‑omics and assay data, prioritizing hypotheses with AI, and closing the loop with automated labs. SaaS accelerates every step—capturing high‑fidelity experimental data, unifying it in governed lakes, powering structure‑ and data‑driven design at scale, orchestrating robots and CROs, and generating audit‑ready evidence for GxP. Teams that … Read more